Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Harbour BioMed and Viva Bio Partner to Offer Incubation Services

publication date: Jul 31, 2020

Harbour BioMed (HBM), a US-China-Netherlands biopharma, formed a strategic partnership with Viva Biotech (Shanghai) to incubate innovative biotech startups. The partnership combines HBM's Harbour Mice® platform for drug discovery with Viva Biotech's structure-based early stage drug discovery services. The companies, which believe the partnership will accelerate the path between idea and product, will provide services on an equity for service (EFS) model. More details....

Stock Symbol: (HK: 1873)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China